- Resistance to HIV drugs
- Summary: Resistance to anti-HIV drugs
- What is resistance?
- Resistance to nucleoside and nucleotide reverse transcriptase inhibitors
- Resistance to non-nucleoside reverse transcriptase inhibitors
- Resistance to protease inhibitors
- Resistance to fusion inhibitors
- Limiting the chance of resistance
- Transmission of resistant HIV
- Resistance in non-B HIV sub-types
- Resistance in tissue and other compartments
- Testing for resistance
- Resistance testing to guide treatment
Resistance to HIV drugs
- Summary: Resistance to anti-HIV drugs
- What is resistance?
- Resistance to nucleoside and nucleotide reverse transcriptase inhibitors
- Resistance to non-nucleoside reverse transcriptase inhibitors
- Resistance to protease inhibitors
- Resistance to fusion inhibitors
- Limiting the chance of resistance
- Transmission of resistant HIV
- Resistance in non-B HIV sub-types
- Resistance in tissue and other compartments
latest aidsmap news
- 'ART as prevention tool' policy announced for British Columbia
- <i>The Lancet</i>: HIV is a global disaster
- Important changes to nevirapine dosing advice made by FDA
- Fatty liver in patients with HIV associated with metabolic abnormalities
- Most HIV infections in Zambia and Rwanda happen in marriage: prevention programmes for couples recommended
- HIV-positive Caribbean people in the UK experience high levels of stigma
- Poverty and unemployment common amongst HIV-positive Londoners
- Risk of death for people with HIV now similar to that seen in the general population
- Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV
- Asymptomatic anal HPV infection more common than thought in heterosexual men